GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) have quickly gained attention for their dramatic effects on weight loss and appetite control. But what happens when these medications enter the world of endurance sport? For triathletes and other athletes training long hours and pushing performance boundaries, the physiological impact of GLP-1 drugs could carry serious consequences. In this blog, we explore what GLP-1 medications are, how they work, and why their use in endurance athletes deserves careful consideration. Whether you're managing a medical condition or simply curious about emerging trends in performance and body composition, this article unpacks the current science, risks, and takeaways for the triathlon community.

What Are GLP-1 and GLP-1 Receptor Agonist Medications? 

Glucagon-like peptide-1 (GLP-1) is a hormone (an incretin) released from the gut after we eat. It helps regulate blood sugar by increasing insulin (when glucose is present) and reducing glucagon,...

A new chapter for Dietitian Approved.

We’re thrilled to share some exciting news! Kelly Estes has joined Dietitian Approved as our Chief Operating Officer (COO).

Kelly isn’t new to our community. He’s a Triathlon Nutrition Academy alumnus and passionate advocate for triathlon nutrition education. Now, he’s stepping into this key leadership role to help us scale with intention and continue delivering world-class nutrition education for endurance athletes across the globe.

About Kelly

Hailing from Idaho, USA, Kelly recently returned to triathlon after a successful career in the nuclear industry, where he held senior leadership positions at the Idaho National Laboratory. His previous roles include Director, Advanced Test Reactor (ATR), Business Affairs Division; Deputy Director, ATR Life Extension Program; Manager, ATR Production Control; and various leadership and project management positions.

Kelly brings decades of experience in operations, project management, and strategic planni...